Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Injecting cosyntropin into grizzly bears increases blood cortisol but doesn't change hair cortisol levels.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Lower zinc levels may predict less effective hair loss treatment.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

Isotretinoin can raise CPK levels, so patients need monitoring, especially before surgery.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Long-term diabetes is linked to lower prostate cancer risk.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Men with early hair loss have lower vitamin D levels.

High testosterone increases heart disease risk in women with PCOS.